2023 Duke-ISCVID Criteria for Infective Endocarditis
Updated 2023 Duke-ISCVID criteria for diagnosis of infective endocarditis (IE), replacing the original 2000 Duke criteria. Incorporates PET/CT and new pathogen definitions.
Score interpretation
Meets the 2023 Duke-ISCVID definite criteria.
→ Treat as IE; endocarditis team.
Meets the possible criteria.
→ Further imaging and cultures; endocarditis team review.
Does not meet definite or possible criteria.
→ Consider alternative diagnoses; reassess if new findings.
Interpretation bands for the Duke-ISCVID 2023. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Featured in these MRCEM clinical pathways
The Duke-ISCVID 2023 is covered in detail — with RCEM/NICE evidence base, indications and pitfalls — in the following exam-focused pathways on our sister siteReviseMRCEM.
MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.